Evidence map›Paper›PMID 33917251›Full record

ArticleInternational journal of environmental research and public health2021

Neuroenhancement in French and Romanian University Students, Motivations and Associated Factors.

Irina Brumboiu, Alessandro Porrovecchio, Thierry Peze, Remy Hurdiel, Irina Cazacu, Cristina Mogosan, Joel Ladner, Marie-Pierre Tavolacci

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Irina BrumboiuCluj-Napoca Unit-The Net-Work of International Francophone Clinical Epidemiology, Iuliu Hatieganu University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania.
Alessandro PorrovecchioUniv. Littoral Côte d'Opale, Univ. Lille Artois ULR 7369-URePSSS-Unité de Recherche Pluridiscipli-Naire Sport Santé Société, F-59375 Dunkerque, France.
Thierry PezeUniv. Littoral Côte d'Opale, Univ. Lille Artois ULR 7369-URePSSS-Unité de Recherche Pluridiscipli-Naire Sport Santé Société, F-59375 Dunkerque, France.ORCID 0000-0003-1761-9953
Remy HurdielUniv. Littoral Côte d'Opale, Univ. Lille Artois ULR 7369-URePSSS-Unité de Recherche Pluridiscipli-Naire Sport Santé Société, F-59375 Dunkerque, France.
Irina CazacuCluj-Napoca Unit-The Net-Work of International Francophone Clinical Epidemiology, Iuliu Hatieganu University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania.ORCID 0000-0002-8011-3261
Cristina MogosanCluj-Napoca Unit-The Net-Work of International Francophone Clinical Epidemiology, Iuliu Hatieganu University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania.ORCID 0000-0002-6854-2194
Joel LadnerClinical Investigation Center 1404 and INSERM 1073, Rouen University Hospital and Rouen Normandie University, 76000 Rouen, France.
Marie-Pierre TavolacciDepartment of Epidemiology and Health Promotion and INSERM 1073, Rouen University Hospital and Rouen Normandie University, 76000 Rouen, France.ORCID 0000-0003-3980-819X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This cross-sectional study aimed to determine the use of neuroenhancers, the motivations and factors associated with their use in French and Romanian university students. Students from two universities in France (Rouen and Opal Coast University) and one in Romania (Cluj-Napoca) were asked to complete a self-administered anonymous questionnaire, either online or on paper, about the use of three different categories of substance: Prescription drugs (methylphenidate, modafinil, and beta-blockers), drugs of abuse (alcohol, cannabis, cocaine, and amphetamines), and soft enhancers (coffee, vitamins, caffeine tablets, and energy drinks). In total, 1110 students were included: The users were 2.2% for prescription drugs, 4.3% for drugs of abuse, and 55.0% for soft enhancers. Students used neuroenhancement to stay awake for study (69.3%), to improve concentration (55.5%), to decrease stress (40.9%), and to improve memory (39.6%). Neuroenhancement was considered to meet expectations by 74.4% of users. The factors associated with the use of drugs of abuse were frequent binge drinking (Adjusted Odds Ratio-AOR: 6.49 [95% CI: 2.53-16.6]), smoking (AOR: 5.50 [95% CI: 2.98-10.14]), having a student job (AOR: 2.42 [95% CI 1.13-5.17]), and being male (AOR: 2.23 [95% CI:1.21-4.11]). No significant associations with eating disorders were detected for any of the three categories of substances. University students reported neuroenhancement with prescription drugs, drugs of abuse, and mainly soft enhancers. These substances were used mainly to increase the waking hours. Educational programs in universities seem to be required in order to increase student awareness of the problems caused by neuroenhancements, and to decrease the associated risks by changing students' attitudes and beliefs.

Indexed as

MotivationUniversitiesCross-Sectional StudiesFranceHumansMaleRomaniaStudentsdrugs of abuseneuroenhancementprescription drugssoft enhancersstudents

Identifiers

PMID33917251
PMCPMC8068007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.